EcoDrugPlus

Ensembl ID : ENSOMYG00000047680
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSOMYG00000047690
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOMYG00000037129
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSOMYG00000048017
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSOMYG00000048109
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSOMYG00000048129
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSOMYG00000030516
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSOMYG00000030500
Gene Symbol: -
Cross references: -
299 Possible Orthologues:

Ensembl ID : ENSOMYG00000048889
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSOMYG00000030493
Gene Symbol: -
Cross references: -
331 Possible Orthologues:

Ensembl ID : ENSOMYG00000054355
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSOMYG00000054559
Gene Symbol: -
Cross references: -
185 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).